Conversion surgery for hepatocellular carcinoma after tyrosine kinase inhibitor treatment.
Kaneko S, Tsuchiya K, Yasui Y, Tanaka Y, Inada K, Ishido S, Kirino S, Yamashita K, Hayakawa Y, Nobusawa T, Matsumoto H, Kakegawa T, Higuchi M, Takaura K, Tanaka S, Maeyashiki C, Tamaki N, Takahashi Y, Nakanishi H, Irie T, Ariizumi SI, Kurosaki M, Izumi N.
Kaneko S, et al.
JGH Open. 2022 Apr 21;6(5):301-308. doi: 10.1002/jgh3.12735. eCollection 2022 May.
JGH Open. 2022.
PMID: 35601130
Free PMC article.